comparemela.com

Latest Breaking News On - Robotic procedures - Page 6 : comparemela.com

TELA Bio's (TELA) "Buy" Rating Reiterated at Canaccord Genuity Group

Canaccord Genuity Group reiterated their buy rating on shares of TELA Bio (NASDAQ:TELA – Get Rating) in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a $15.00 price target on the stock. Separately, JMP Securities restated a market outperform rating and set a $20.00 price target on shares of […]

Rock-asset-management
Renaissance-technologies
Blackrock-inc
Bio-inc
Morgan-stanley
Capital-management
Canaccord-genuity-group
Sbio-company-profile
Get-rating
Ovitex-reinforced-tissue-matrix
Tissue-matrix

Canaccord Genuity Group Reaffirms "Buy" Rating for TELA Bio (NASDAQ:TELA)

Canaccord Genuity Group restated their buy rating on shares of TELA Bio (NASDAQ:TELA – Get Rating) in a report released on Tuesday, Benzinga reports. Canaccord Genuity Group currently has a $15.00 target price on the stock. Separately, JMP Securities reaffirmed a market outperform rating and set a $20.00 price objective on shares of TELA Bio […]

Canaccord-genuity-group
Susquehanna-international-group
Millennium-management
Nasdaq
Morgan-stanley
Capital-management
Schonfeld-strategic-advisors
Bio-inc
Get-rating
Genuity-group
Strategic-advisors

TELA Bio (NASDAQ:TELA) Rating Reiterated by Canaccord Genuity Group

Canaccord Genuity Group reaffirmed their buy rating on shares of TELA Bio (NASDAQ:TELA – Get Rating) in a research note published on Tuesday, Benzinga reports. The firm currently has a $15.00 price target on the stock. Separately, JMP Securities restated a market outperform rating and issued a $20.00 price objective on shares of TELA Bio […]

Parkman-healthcare-partners
Boothbay-fund-management
Perkins-capital-management-inc
Bio-inc
Nantahala-capital-management
Rock-asset-management
Canaccord-genuity-group
Get-rating
Capital-management
Healthcare-partners
Fund-management

TELA Bio, Inc. Expected to Post Q1 2023 Earnings of ($0.53) Per Share (NASDAQ:TELA)

TELA Bio, Inc. (NASDAQ:TELA – Get Rating) – Analysts at Jefferies Financial Group issued their Q1 2023 earnings per share estimates for TELA Bio in a research report issued to clients and investors on Tuesday, March 21st. Jefferies Financial Group analyst M. Sarcone expects that the company will post earnings per share of ($0.53) for […]

Schonfeld-strategic-advisors
Bio-inc
Capital-management
Susquehanna-international-group
Morgan-stanley
Analysts-at-jefferies-financial-group
Millennium-management
Sbio-company-profile
Tela-bio-inc
Jefferies-financial-group
Nasdaq

TELA Bio, Inc. (NASDAQ:TELA) to Post Q4 2023 Earnings of ($0.50) Per Share, Jefferies Financial Group Forecasts

TELA Bio, Inc. (NASDAQ:TELA – Get Rating) – Analysts at Jefferies Financial Group issued their Q4 2023 EPS estimates for shares of TELA Bio in a report issued on Tuesday, March 21st. Jefferies Financial Group analyst M. Sarcone anticipates that the company will post earnings of ($0.50) per share for the quarter. The consensus estimate […]

Vanguard-group-inc
Analysts-at-jefferies-financial-group
Opaleye-management-inc
Capital-management
Essex-woodlands-management-inc
Tela-bio-inc
Sbio-company-profile
Bio-inc
Jefferies-financial-group
Nasdaq
Get-rating

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.